Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback